APODAGRA
Live / Registered — Registered — Section 8 accepted (as of 18 Sept 2026)
What this means for you
Registered since 13 Oct 2020. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 13 Oct 2030: the §8 & §9 renewal).
Record
- Serial number
- 87316482
- Registration number
- 6175488
- Mark type
- Word mark
- Filed
- 27 Jan 2017
- Published for opposition
- 04 Jul 2017
- Registered
- 13 Oct 2020
- Next maintenance filing
- §8 & §9 renewal, due by 13 Oct 2030 (grace period to 13 Apr 2031)
- Attorney of record
- Sean B. MacKenzie
Goods and services
- Class 005 — Pharmaceuticals: Over the counter pharmaceutical preparation remedy for gout pain relief
Owner
- Nexzol Pharma, Inc., San Clemente, CA, US
- Nexzol Pharma, Inc., San Clemente, CA, US
- Nuremedy Pharma LLC, Las Vegas, NV, US
- Nuremedy Pharma LLC, Las Vegas, NV, US
Prosecution history
- 18 Sept 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 18 Sept 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 17 Sept 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 17 Jul 2026 — TEAS SECTION 8 RECEIVED
- 13 Oct 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 13 Oct 2020 — REGISTERED-PRINCIPAL REGISTER
- 11 Sept 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 Sept 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 24 Aug 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 18 Aug 2020 — USE AMENDMENT FILED
- 18 Aug 2020 — TEAS STATEMENT OF USE RECEIVED
- 08 Jan 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Jan 2020 — SOU EXTENSION 5 GRANTED
- 12 Dec 2019 — SOU EXTENSION 5 FILED
- 12 Dec 2019 — SOU TEAS EXTENSION RECEIVED